Jingru Wang

Jingru Wang has extensive experience in the pharmaceutical industry, with their most recent position being Senior Director of Clinical Development at CStone Pharmaceuticals since October 2022. Prior to that, they held roles such as Director of Clinical Development and Associate Director of Clinical Science at the same company. Before joining CStone Pharmaceuticals, Jingru worked at Eli Lilly China, where they gained experience as a Scientist III, Scientist II, and Scientist I. Jingru began their career as a Senior Research Assistant at the Shanghai Institute of Medical Materiia, Chinese Academy of Sciences.

Jingru Wang holds a Doctor of Philosophy degree in Neuropharmacology from Shanghai Institute of Materia Medica, CAS, which was completed from 2005 to 2009. Prior to that, Jingru Wang obtained a bachelor's degree in Pharmaceutical Science and Technology from Jilin University from 1998 to 2002. Additionally, from 2002 to 2004, Jingru Wang attended Shenyang Pharmaceutical University and earned a Master's degree.